Evidence-based, pharmacological treatment guideline for depression in Korea, revised edition

Eunsoo Won, Seon Cheol Park, Kyu Man Han, Seung Hwan Sung, Hwa Young Lee, Jong Woo Paik, Hong Jin Jeon, Moon-Soo Lee, Se Hoon Shim, Young-Hoon Ko, Kang Joon Lee, Changsu Han, Byung-Joo Ham, Joonho Choi, Tae Yeon Hwang, Kang Seob Oh, Sang Woo Hahn, Yong Chon Park, Min-Soo Lee

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

This paper aims to introduce, summarize, and emphasize the importance of the 'Evidence-Based, Pharmacological Treatment Guideline for Depression in Korea, Revised Edition'. The guideline broadly covers most aspects of the pharmacological treatment of patients in Korea diagnosed with moderate to severe major depression according to the DSM-IV TR. The guideline establishment process involved determining and answering a number of key questions, searching and selecting publications, evaluating recommendations, preparing guideline drafts, undergoing external expert reviews, and obtaining approval. A guideline adaptation process was conducted for the revised edition. The guideline strongly recommends pharmacological treatment considered appropriate to the current clinical situation in Korea, and should be considered helpful when selecting the appropriate pharmacological treatment of patients diagnosed with major depressive disorder. Therefore, the wide distribution of this guideline is recommended.

Original languageEnglish
Pages (from-to)468-484
Number of pages17
JournalJournal of Korean Medical Science
Volume29
Issue number4
DOIs
Publication statusPublished - 2014 Jan 1

Fingerprint

Korea
Pharmacology
Guidelines
Depression
Therapeutics
Major Depressive Disorder
Diagnostic and Statistical Manual of Mental Disorders
Publications

Keywords

  • Depression
  • Guideline
  • Korea
  • Pharmacological Treatment

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Won, E., Park, S. C., Han, K. M., Sung, S. H., Lee, H. Y., Paik, J. W., ... Lee, M-S. (2014). Evidence-based, pharmacological treatment guideline for depression in Korea, revised edition. Journal of Korean Medical Science, 29(4), 468-484. https://doi.org/10.3346/jkms.2014.29.4.468

Evidence-based, pharmacological treatment guideline for depression in Korea, revised edition. / Won, Eunsoo; Park, Seon Cheol; Han, Kyu Man; Sung, Seung Hwan; Lee, Hwa Young; Paik, Jong Woo; Jeon, Hong Jin; Lee, Moon-Soo; Shim, Se Hoon; Ko, Young-Hoon; Lee, Kang Joon; Han, Changsu; Ham, Byung-Joo; Choi, Joonho; Hwang, Tae Yeon; Oh, Kang Seob; Hahn, Sang Woo; Park, Yong Chon; Lee, Min-Soo.

In: Journal of Korean Medical Science, Vol. 29, No. 4, 01.01.2014, p. 468-484.

Research output: Contribution to journalArticle

Won, E, Park, SC, Han, KM, Sung, SH, Lee, HY, Paik, JW, Jeon, HJ, Lee, M-S, Shim, SH, Ko, Y-H, Lee, KJ, Han, C, Ham, B-J, Choi, J, Hwang, TY, Oh, KS, Hahn, SW, Park, YC & Lee, M-S 2014, 'Evidence-based, pharmacological treatment guideline for depression in Korea, revised edition', Journal of Korean Medical Science, vol. 29, no. 4, pp. 468-484. https://doi.org/10.3346/jkms.2014.29.4.468
Won, Eunsoo ; Park, Seon Cheol ; Han, Kyu Man ; Sung, Seung Hwan ; Lee, Hwa Young ; Paik, Jong Woo ; Jeon, Hong Jin ; Lee, Moon-Soo ; Shim, Se Hoon ; Ko, Young-Hoon ; Lee, Kang Joon ; Han, Changsu ; Ham, Byung-Joo ; Choi, Joonho ; Hwang, Tae Yeon ; Oh, Kang Seob ; Hahn, Sang Woo ; Park, Yong Chon ; Lee, Min-Soo. / Evidence-based, pharmacological treatment guideline for depression in Korea, revised edition. In: Journal of Korean Medical Science. 2014 ; Vol. 29, No. 4. pp. 468-484.
@article{ce9b31b83dbb42dc8677be4a549c1ce3,
title = "Evidence-based, pharmacological treatment guideline for depression in Korea, revised edition",
abstract = "This paper aims to introduce, summarize, and emphasize the importance of the 'Evidence-Based, Pharmacological Treatment Guideline for Depression in Korea, Revised Edition'. The guideline broadly covers most aspects of the pharmacological treatment of patients in Korea diagnosed with moderate to severe major depression according to the DSM-IV TR. The guideline establishment process involved determining and answering a number of key questions, searching and selecting publications, evaluating recommendations, preparing guideline drafts, undergoing external expert reviews, and obtaining approval. A guideline adaptation process was conducted for the revised edition. The guideline strongly recommends pharmacological treatment considered appropriate to the current clinical situation in Korea, and should be considered helpful when selecting the appropriate pharmacological treatment of patients diagnosed with major depressive disorder. Therefore, the wide distribution of this guideline is recommended.",
keywords = "Depression, Guideline, Korea, Pharmacological Treatment",
author = "Eunsoo Won and Park, {Seon Cheol} and Han, {Kyu Man} and Sung, {Seung Hwan} and Lee, {Hwa Young} and Paik, {Jong Woo} and Jeon, {Hong Jin} and Moon-Soo Lee and Shim, {Se Hoon} and Young-Hoon Ko and Lee, {Kang Joon} and Changsu Han and Byung-Joo Ham and Joonho Choi and Hwang, {Tae Yeon} and Oh, {Kang Seob} and Hahn, {Sang Woo} and Park, {Yong Chon} and Min-Soo Lee",
year = "2014",
month = "1",
day = "1",
doi = "10.3346/jkms.2014.29.4.468",
language = "English",
volume = "29",
pages = "468--484",
journal = "Journal of Korean Medical Science",
issn = "1011-8934",
publisher = "Korean Academy of Medical Science",
number = "4",

}

TY - JOUR

T1 - Evidence-based, pharmacological treatment guideline for depression in Korea, revised edition

AU - Won, Eunsoo

AU - Park, Seon Cheol

AU - Han, Kyu Man

AU - Sung, Seung Hwan

AU - Lee, Hwa Young

AU - Paik, Jong Woo

AU - Jeon, Hong Jin

AU - Lee, Moon-Soo

AU - Shim, Se Hoon

AU - Ko, Young-Hoon

AU - Lee, Kang Joon

AU - Han, Changsu

AU - Ham, Byung-Joo

AU - Choi, Joonho

AU - Hwang, Tae Yeon

AU - Oh, Kang Seob

AU - Hahn, Sang Woo

AU - Park, Yong Chon

AU - Lee, Min-Soo

PY - 2014/1/1

Y1 - 2014/1/1

N2 - This paper aims to introduce, summarize, and emphasize the importance of the 'Evidence-Based, Pharmacological Treatment Guideline for Depression in Korea, Revised Edition'. The guideline broadly covers most aspects of the pharmacological treatment of patients in Korea diagnosed with moderate to severe major depression according to the DSM-IV TR. The guideline establishment process involved determining and answering a number of key questions, searching and selecting publications, evaluating recommendations, preparing guideline drafts, undergoing external expert reviews, and obtaining approval. A guideline adaptation process was conducted for the revised edition. The guideline strongly recommends pharmacological treatment considered appropriate to the current clinical situation in Korea, and should be considered helpful when selecting the appropriate pharmacological treatment of patients diagnosed with major depressive disorder. Therefore, the wide distribution of this guideline is recommended.

AB - This paper aims to introduce, summarize, and emphasize the importance of the 'Evidence-Based, Pharmacological Treatment Guideline for Depression in Korea, Revised Edition'. The guideline broadly covers most aspects of the pharmacological treatment of patients in Korea diagnosed with moderate to severe major depression according to the DSM-IV TR. The guideline establishment process involved determining and answering a number of key questions, searching and selecting publications, evaluating recommendations, preparing guideline drafts, undergoing external expert reviews, and obtaining approval. A guideline adaptation process was conducted for the revised edition. The guideline strongly recommends pharmacological treatment considered appropriate to the current clinical situation in Korea, and should be considered helpful when selecting the appropriate pharmacological treatment of patients diagnosed with major depressive disorder. Therefore, the wide distribution of this guideline is recommended.

KW - Depression

KW - Guideline

KW - Korea

KW - Pharmacological Treatment

UR - http://www.scopus.com/inward/record.url?scp=84899834382&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899834382&partnerID=8YFLogxK

U2 - 10.3346/jkms.2014.29.4.468

DO - 10.3346/jkms.2014.29.4.468

M3 - Article

VL - 29

SP - 468

EP - 484

JO - Journal of Korean Medical Science

JF - Journal of Korean Medical Science

SN - 1011-8934

IS - 4

ER -